The University of Chicago Header Logo

Andrew Aronsohn

Concepts (150)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
14
2021
512
4.380
Why?
Hepatitis C
11
2022
210
3.860
Why?
Hepatitis C, Chronic
7
2020
126
2.780
Why?
Hepacivirus
5
2022
160
1.590
Why?
Gastroenterology
4
2021
140
1.390
Why?
Lactulose
1
2023
20
0.930
Why?
Hepatic Encephalopathy
1
2023
42
0.920
Why?
Liver Diseases
2
2016
239
0.830
Why?
Internship and Residency
4
2021
1010
0.800
Why?
Ribavirin
2
2013
58
0.800
Why?
Hypereosinophilic Syndrome
1
2021
5
0.790
Why?
Hepatitis, Autoimmune
1
2021
20
0.780
Why?
Off-Label Use
2
2014
16
0.590
Why?
Health Services Accessibility
3
2017
394
0.560
Why?
Hepatitis B, Chronic
1
2015
32
0.520
Why?
Interferon-alpha
2
2013
234
0.520
Why?
Informed Consent
2
2020
266
0.510
Why?
Viral Load
2
2021
150
0.490
Why?
Medicaid
1
2017
217
0.480
Why?
Polyethylene Glycols
2
2013
364
0.470
Why?
Interferons
1
2014
133
0.460
Why?
Drug Discovery
1
2013
103
0.410
Why?
Liver Transplantation
4
2023
1271
0.390
Why?
Curriculum
4
2021
542
0.390
Why?
Biliary Tract Diseases
1
2011
34
0.390
Why?
Resource Allocation
1
2011
65
0.380
Why?
Humans
28
2023
86656
0.380
Why?
Health Care Rationing
1
2011
83
0.380
Why?
Renal Insufficiency, Chronic
1
2015
349
0.380
Why?
Patient Participation
1
2012
216
0.370
Why?
Treatment Outcome
8
2021
7982
0.350
Why?
Liver Cirrhosis
3
2016
300
0.320
Why?
Tissue and Organ Procurement
1
2010
311
0.270
Why?
United States
7
2021
6674
0.260
Why?
Healthcare Disparities
2
2021
372
0.250
Why?
Vulnerable Populations
1
2022
76
0.210
Why?
United States Food and Drug Administration
2
2014
127
0.210
Why?
Proline
2
2013
57
0.210
Why?
Viremia
1
2021
55
0.190
Why?
Oligopeptides
2
2013
180
0.190
Why?
Donor Selection
1
2021
68
0.190
Why?
Azathioprine
1
2021
125
0.190
Why?
Prednisone
1
2021
258
0.190
Why?
Beneficence
1
2020
33
0.190
Why?
Risk Assessment
4
2021
2261
0.180
Why?
Drug Therapy, Combination
2
2014
895
0.170
Why?
Recombinant Proteins
2
2013
1018
0.170
Why?
Immunoglobulin G
1
2021
457
0.170
Why?
Glucocorticoids
1
2021
350
0.160
Why?
Anti-Bacterial Agents
1
2023
747
0.160
Why?
Ethics, Medical
1
2021
306
0.160
Why?
Tissue Donors
1
2021
465
0.160
Why?
Female
10
2021
44566
0.160
Why?
Legislation, Drug
1
2017
6
0.150
Why?
Gastrointestinal Microbiome
1
2023
459
0.150
Why?
Paracentesis
1
2016
9
0.140
Why?
Coinfection
2
2015
58
0.140
Why?
Flaviviridae Infections
1
2015
1
0.140
Why?
GB virus C
1
2015
1
0.140
Why?
Ascites
1
2016
56
0.140
Why?
Hepatitis, Viral, Human
1
2015
25
0.140
Why?
Internal Medicine
2
2016
349
0.130
Why?
Practice Patterns, Physicians'
1
2021
584
0.130
Why?
Immunosuppressive Agents
1
2021
977
0.130
Why?
Deficiency Diseases
1
2015
11
0.130
Why?
Career Choice
1
2016
141
0.130
Why?
Comorbidity
2
2015
945
0.130
Why?
Zinc
1
2015
92
0.120
Why?
Liver Failure
1
2015
79
0.120
Why?
Drug and Narcotic Control
1
2014
7
0.120
Why?
Time Factors
4
2021
5215
0.120
Why?
Middle Aged
6
2021
25027
0.120
Why?
Viral Nonstructural Proteins
1
2014
37
0.120
Why?
Protease Inhibitors
1
2014
72
0.120
Why?
Drug Design
1
2014
124
0.120
Why?
Male
8
2021
40995
0.120
Why?
Liver Neoplasms
1
2020
736
0.120
Why?
Drug Administration Schedule
1
2015
915
0.120
Why?
Acquired Immunodeficiency Syndrome
1
2014
78
0.120
Why?
Hepatitis B
1
2014
74
0.120
Why?
Drug Industry
1
2014
54
0.110
Why?
Disease Management
1
2015
328
0.110
Why?
Chronic Disease
1
2016
972
0.110
Why?
Algorithms
2
2020
1830
0.110
Why?
Truth Disclosure
1
2012
87
0.100
Why?
Molecular Targeted Therapy
1
2014
266
0.100
Why?
Dose-Response Relationship, Drug
1
2015
1960
0.100
Why?
Education, Medical, Graduate
1
2015
373
0.100
Why?
Physicians
1
2018
673
0.100
Why?
Clinical Competence
1
2016
756
0.100
Why?
Recurrence
1
2013
1139
0.090
Why?
Hospitalization
1
2016
851
0.090
Why?
Cohort Studies
2
2015
2765
0.090
Why?
Animals
2
2023
26706
0.090
Why?
Postoperative Period
1
2011
302
0.090
Why?
Decision Trees
1
2020
63
0.090
Why?
Severity of Illness Index
1
2015
1804
0.090
Why?
Mice
1
2023
11439
0.090
Why?
Precision Medicine
1
2013
395
0.090
Why?
Age Factors
1
2013
1849
0.080
Why?
Practice Guidelines as Topic
1
2015
1037
0.080
Why?
Critical Illness
1
2011
295
0.080
Why?
Prognosis
1
2015
3681
0.080
Why?
Critical Care
1
2011
371
0.080
Why?
Physician-Patient Relations
1
2012
610
0.070
Why?
Aged, 80 and over
2
2015
6511
0.070
Why?
Databases, Factual
2
2021
816
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2009
508
0.060
Why?
Mass Screening
2
2022
619
0.060
Why?
Aged
4
2016
18407
0.060
Why?
HIV Infections
1
2013
773
0.060
Why?
Clinical Trials as Topic
1
2009
1169
0.060
Why?
Fatty Acids
1
2023
130
0.060
Why?
Dysbiosis
1
2023
70
0.060
Why?
Feces
1
2023
320
0.050
Why?
Adult
3
2021
25648
0.050
Why?
Colorectal Neoplasms
1
2009
938
0.050
Why?
Risk Factors
3
2021
5416
0.050
Why?
RNA, Viral
1
2021
330
0.050
Why?
Clinical Decision-Making
1
2021
257
0.040
Why?
Chicago
1
2022
1380
0.040
Why?
Graft Survival
1
2021
885
0.040
Why?
Quality Improvement
1
2021
427
0.040
Why?
Cost Savings
1
2016
67
0.030
Why?
Hospital Costs
1
2016
107
0.030
Why?
Hospitals, University
1
2015
194
0.030
Why?
Quality Indicators, Health Care
1
2016
145
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2015
276
0.030
Why?
Early Diagnosis
1
2015
132
0.030
Why?
Statistics, Nonparametric
1
2015
308
0.030
Why?
Needs Assessment
1
2015
154
0.030
Why?
Hospital Mortality
1
2016
350
0.030
Why?
Linear Models
1
2015
421
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
881
0.030
Why?
Cost-Benefit Analysis
1
2016
453
0.030
Why?
Length of Stay
1
2016
704
0.030
Why?
Kaplan-Meier Estimate
1
2015
861
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2015
456
0.030
Why?
Multivariate Analysis
1
2015
999
0.030
Why?
Base Sequence
1
2015
2335
0.030
Why?
Molecular Sequence Data
1
2015
3035
0.020
Why?
Survival Rate
1
2015
1864
0.020
Why?
Phylogeny
1
2015
1137
0.020
Why?
Disease Progression
1
2015
1534
0.020
Why?
Tomography, X-Ray Computed
1
2020
2585
0.020
Why?
Family Health
1
2009
162
0.020
Why?
Health Education
1
2009
101
0.020
Why?
Follow-Up Studies
1
2015
3639
0.020
Why?
Retrospective Studies
1
2015
8476
0.010
Why?
Genetic Predisposition to Disease
1
2009
2272
0.010
Why?
Aronsohn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (150)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_